Candesartan benefits and safety observed regardless of age. Insights from the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Cohen-Solal, Alain
  • Swedberg, Karl
  • Mc Murray, John
  • Pfeffer, Marc
  • Olofsson, Bertil
  • Michelson, Eric
  • Yusuf, Salim
  • Granger, Christopher

publication date

  • March 6, 2007